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Vibrio parahaemolyticus type III secretion system 2
(T3SS2) is essential for the organism’s virulence, but
the effectors required for intestinal colonization and
induction of diarrhea by this pathogen have not been
identified. Here,we identify a type III secretion system
(T3SS2)-secreted effector, VopZ, that is essential for
V. parahaemolyticus pathogenicity. VopZ plays
distinct, genetically separable roles in enabling intes-
tinal colonization and diarrheagenesis. Truncation of
VopZ prevents V. parahaemolyticus colonization,
whereas deletion of VopZ amino acids 38–62 abro-
gates V. parahaemolyticus-induced diarrhea and
intestinal pathology but does not impair colonization.
VopZ inhibits activation of the kinase TAK1 and
thereby prevents the activation of MAPK and NF-kB
signaling pathways, which lie downstream. In con-
trast, the VopZ internal deletion mutant cannot
counter the activation of pathways regulated by
TAK1. Collectively, our findings suggest that VopZ’s
inhibition of TAK1 is critical for V. parahaemolyticus
to induce diarrhea and intestinal pathology.
INTRODUCTION
Vibrio parahaemolyticus is a leading cause of diarrhea linked
to the consumption of contaminated seafood worldwide
(Su and Liu, 2007). Biopsies from patients infected with
V. parahaemolyticus show disruption of the intestinal epithelium
along with evidence of inflammation (Qadri et al., 2003), and
similar signs of disease have been observed in ligated ileal loops
in infected adult rabbits and in orally infected infant rabbits, both
of which are used as animal models of V. parahaemolyticus
infection (Park et al., 2004; Ritchie et al., 2012). Analyses using
these and other animal models strongly suggest that the viru-
lence of this organism is dependent upon a type III secretion
system (T3SS) encoded on V. parahaemolyticus chromosome1690 Cell Reports 3, 1690–1702, May 30, 2013 ª2013 The AuthorsII (T3SS2) (Park et al., 2004; Hiyoshi et al., 2010; Pin˜eyro et al.,
2010; Ritchie et al., 2012). Strains lacking a functional T3SS2
fail to colonize the intestine of infant rabbits; they also do not
induce signs of disease in ligated ileal loops, where factors
that contribute solely to colonization are dispensable, sug-
gesting that T3SS2 contributes to multiple facets of patho-
genesis. An additional secretion system (T3SS1, encoded on
chromosome I) has been linked to a variety of phenotypes in
tissue culture-based assays, including cytotoxicity and cytokine
induction (Park et al., 2004; Bhattacharjee et al., 2006; Burdette
et al., 2008, 2009; Shimohata and Takahashi, 2010; Zhou et al.,
2010; Broberg et al., 2011); however, T3SS1 appears to play
only a minor role in pathogenesis within the gastrointestinal
tract (Park et al., 2004; Ritchie et al., 2012). T3SS1 may
instead contribute to V. parahaemolyticus interactions with
some marine host(s) because this T3SS is found in all
V. parahaemolyticus strains, including environmental/nonpatho-
genic isolates (Makino et al., 2003). In contrast, T3SS2 is largely
absent from environmental/nonpathogenic isolates (Park et al.,
2004).
T3SSs are essential for the virulence of several other Gram-
negative pathogens, and they are used by bacteria tomanipulate
a variety of host cell processes that influence pathogen survival
and growth (Coburn et al., 2007; Dean, 2011). These multi-
component molecular machines enable bacteria to transport
proteins, referred to as ‘‘effectors,’’ from the bacterial cytoplasm,
where they are synthesized, directly into the eukaryotic cell
cytoplasm. Release of effectors from bacteria is typically
triggered by contact between the pathogen and the host; how-
ever, secretion-inducing stimuli that are independent of host
cells have also been identified. Effectors have been found to
dampen the innate immune response, inhibit phagocytosis,
reorganize cytoskeletal proteins to promote pathogen internali-
zation, and modulate several other processes (Cornelis, 2006;
Gala´n, 2009), and a single secretion system routinely transports
multiple effectors with disparate functions. Some effectors have
homologs that are translocated by secretion systems in a variety
of organisms, whereas others are specific to a particular bacte-
rial species or strain. In general, effectors show less cross-
species conservation than do the structural components of the
secretion apparati. Effectors are often, but not always, encoded
adjacent to genes encoding the secretion machinery that
enables their translocation.
To date, five effectors that are translocated by
V. parahaemolyticus T3SS2 have been identified, all of which
are encoded within or near the T3SS2 gene cluster. These pro-
teins include a Ser/Thr acetyltransferase (VopA; Trosky et al.,
2007), an actin nucleator (VopL; Liverman et al., 2007), an ADP
ribosyltransferase (VopT; Kodama et al., 2007), an actin-
bundling protein (VopV; Hiyoshi et al., 2011), and a homolog of
cytotoxic-necrotizing factor, a deamidase (VopC; Akeda et al.,
2011). However, with the exception of VopV, which has been
shown to be critical for V. parahaemolyticus-induced enterotox-
icity in rabbit ileal loops, there is no knowledge of the role of
T3SS2 effectors in intestinal colonization or the pathogenesis
of diarrhea, epithelial disruption, or inflammation caused by
V. parahaemolyticus.
Here, we used two-dimensional (2D) gel electrophoresis to
identify two proteins secreted by T3SS2, VPA1336 and
VPA1350, as well as the likely needle component of T3SS2
(VPA1343). VPA1336, here renamed VopZ, proved to be a multi-
functional effector that is essential for V. parahaemolyticus to
colonize the intestine and to induce diarrhea. Notably, these
two key virulence-related phenotypes appear to require
different regions of VopZ. A V. parahaemolyticus mutant with
a truncated vopZ did not colonize or cause diarrhea, whereas
a mutant harboring a small internal deletion in vopZ robustly
colonized but did not cause diarrhea or intestinal pathology.
We demonstrate that VopZ inhibits activation of the mitogen-
activated protein kinase kinase kinase MAP3K7 (also called
transforming growth factor b-activated kinase, or TAK1),
a kinase important for the activation of both MAPK and NF-kB
signaling pathways (Sakurai, 2012). In contrast, the VopZ
internal deletion mutant cannot counter activation of pathways
regulated by TAK1. Thus, VopZ’s inhibition of TAK1 is dis-
pensable for intestinal colonization by V. parahaemolyticus;
however, it appears to be required for V. parahaemolyticus
to cause intestinal pathology, including diarrhea and tissue
disruption.
RESULTS
Previously Identified T3SS2 Effectors Do Not Play
an Essential Role in Intestinal Colonization or Fluid
Accumulation
Our group recently reported that infant rabbits are useful
model hosts to investigate V. parahaemolyticus pathogenicity
(Ritchie et al., 2012; Zhou et al., 2012b). Because we found
that T3SS2 is critical for colonization, intestinal pathology,
and diarrhea (Ritchie et al., 2012), we set out to identify and
characterize T3SS2 effectors that could account for its pivotal
role in pathogenesis. Our initial studies revealed that a
V. parahaemolyticus mutant strain (derived from wild-type
[WT] strain RIMD2210633; Makino et al., 2003) lacking the
only three effectors confirmed at that time (VopT, VopA, and
VopL) was fully pathogenic. The mutant and WT strains were
equivalent in their ability to colonize rabbit intestines and
induce diarrhea, intestinal fluid accumulation, and intestinalCpathology (Figure S1; data not shown). The marked difference
between the virulence of the vopT vopL vopA triple mutant
and the vscN2 mutant suggested that heretofore-unidentified
T3SS2 effectors are essential for V. parahaemolyticus intestinal
colonization and disease.
Identification of T3SS2-Secreted Proteins
To identify T3SS2-secreted effectors, we used 2D difference gel
electrophoresis (DIGE) to compare proteins secreted by a
T3SS1-deficient strain (RIMD2210633 vscN1; Hiyoshi et al.,
2010) and a T3SS1/T3SS2-deficient strain (RIMD2210633
vscN1 vscN2; Hiyoshi et al., 2010). This approach enabled detec-
tion of 30 potential T3SS2-dependent-secreted proteins, 23 of
which were found to be encoded by V. parahaemolyticus, and
19 of which were encoded in the genomic island that yields
T3SS2 (Figure 1). The T3SS2-encoded polypeptides (derived
from 11 annotated proteins) included VopL, VopT, VopA, two
effectors reported to be secreted via T3SS2 after this study
was initiated (VopV and VopC) (Akeda et al., 2011; Hiyoshi
et al., 2011), VopD2 and VopW (components of the T3SS2 trans-
locon, a portion of the secretion apparatus that is itself often
secreted) (Kodama et al., 2008; Zhou et al., 2012b), and VopcC,
which is thought to function as the chaperone for VopC (Akeda
et al., 2011). Additionally, the uncharacterized T3SS2-encoded
proteins VPA1336 (named here VopZ), VPA1350, and VPA1343
appeared to be secreted in a T3SS2-dependent fashion. Secre-
tion of VPA1336 and VPA1350 was also suggested by recent
observations using a heterologous expression system (Zhou
et al., 2012a).
VPA1350 and VPA1343 Are Required for T3SS2-
Dependent Protein Secretion and/or Translocation
As an initial step in determining the significance of previously
uncharacterized potential effectors, we examined whether
strains harboring mutations in vpa1343, vopZ, or vpa1350
were impaired for secretion or translocation of known
T3SS2 substrates. Neither deletion of vpa1350 nor introduc-
tion of a stop codon into amino acid (aa) 41 of the VPA1336
ORF (subsequently termed vopZ0) reduced release of VopD2
into culture supernatants; however, supernatant from a
vpa1343 deletion mutant did not contain detectable VopD2,
despite the presence of this protein in cell pellets (Figure S2A).
These results suggest that VPA1343 is either a component of
the T3SS2 secretion apparatus or that the vpa1343 deletion
had polar effects. Consistent with the former possibility,
bioinformatic analysis (http://www.sbg.bio.ic.ac.uk/phyre2/
html/page.cgi?id=index; Kelley and Sternberg, 2009) suggests
that VPA1343 is a structural homolog of PrgI, the needle
protein for the Salmonella enteriditis SPI-1 T3SS. Subsequent
immunofluorescence microscopy-based analyses of effector
translocation by the vopZ0 and vpa1350 mutants revealed
that vpa1350 (but not vopZ) is required for this process;
translocation of VopV was equivalent from a vscN1 mutant
(the positive control strain) and from a vscN1 vopZ0 mutant,
whereas no VopV translocation was apparent from the
vpa1350 deletion mutant (Figure S2). Thus, it seems likely
that VPA1350, like VPA1343, plays a structural or regulatory
role in the translocation process. The relative abundance of
VPA1350 seen with DIGE is also consistent with its being aell Reports 3, 1690–1702, May 30, 2013 ª2013 The Authors 1691
Figure 1. Identification of T3SS2-Secreted
Polypeptides
(A) DIGE of supernatant-derived proteins
from a T3SS1-deficient strain (RIMD2210633
vscN1; red) and a T3SS1/T3SS2-deficient strain
(RIMD2210633 vscN1 vscN2; green). Spots
selected for MALDI tandem mass spectrometry
are circled, and protein identities and functions are
indicated below.
(B) Schematic depiction of the T3SS2 region from
V. parahaemolyticus RIMD2210633, including
most genes from vpa1321 to vpa1370. Genes
encoding effectors are colored red; genes
encoding structural components are colored
gray. The transcriptional regulator vtrB (vpa1348)
is colored black.
(C) Identity of the spots identified from DIGE and
mass spectrometry. Black print shows proteins
encoded in T3SS2, gray print indicates proteins
encoded outside of T3SS2, and red type indicates
effector proteins. Final column shows whether
T3SS2-dependent secretion has been confirmed:
yes (Y), no (N), not determined (ND). Asterisk
indicates previously unidentified T3SS2-secreted
proteins.component of the secretion apparatus; structural proteins were
in general significantly more abundant than were effectors
(Figure 1).
VopZ Is Translocated into Eukaryotic Cells
in a T3SS2-Dependent Manner
Western blot analyses (data not shown) confirmed the initial
DIGE-based observation that VopZ (and also VPA1350) is
secreted into culture supernatants in a T3SS2-dependent
manner. Furthermore, by comparing cAMP activity in Caco-2
cells infected with vscN1 or vscN1 vscN2 V. parahaemolyticus
strains that produce various effector-Cya (adenylate cyclase)
fusion proteins, we found that VopZ-Cya is translocated as
efficiently as the known effector VopV (Figure S2C). Thus, in
contrast to VPA1350 and VPA1343, VopZ appears to be a
secreted and translocated protein that, likemost T3SS effectors,
is not required for secretion or translocation of other T3SS2
substrates.1692 Cell Reports 3, 1690–1702, May 30, 2013 ª2013 The AuthorsVopZ Forms Punctae in HeLa Cells
N-terminally HA-tagged VopZ formed
discrete cytoplasmic punctae in trans-
fected HeLa cells (Figure S3). Trans-
fection of a series of truncated vopZ
derivatives suggested that aa 38–62 of
VopZ are important for puncta formation
(Figure S3); in the absence of these aa
(e.g., VopZ63–251 and VopZD38–62),
VopZ was distributed diffusely in the
HeLa cell cytoplasm. Notably, this region
of VopZ is highly conserved among VopZ
homologs (which are all hypothetical,
uncharacterized proteins), suggesting
that it may be important for VopZ func-tion. BLAST and Phyre analyses of VopZ did not reveal the pres-
ence of known conserved domains or significant similarities with
known protein structures.
VopZ Is Required for the T3SS2-Dependent Inhibition
of IL-8 Secretion
In previous studies, T3SS2 was reported to limit production
of transcripts for IL-8, a proinflammatory CXC chemokine
(Matlawska-Wasowska et al., 2010); however, no T3SS2
effector was linked to this phenotype. Therefore, we explored
whether VopZ modulates production of IL-8 by infected
HEK293 and HeLa cells. Experiments were performed with
bacteria lacking vscN1, an integral component of T3SS1,
because this system induces host cell cytotoxicity and lysis
that complicates other analyses. As previously reported, we
found that T3SS2 suppresses IL-8 production in response to
V. parahaemolyticus infection: a vscN1 vscN2 strain, in which
both T3SS1 and T3SS2 are inactive, induced markedly more
IL-8 secretion by HEK293 cells than did a vscN1 strain.
Notably, this suppression appears to be entirely dependent
upon VopZ because the vscN1 vopZ0 and vscN1 vscN2
mutants similarly induced IL-8 production (Figure 2A). VopZ
also blocks IL-8 upregulation by HEK293 cells in response to
TNF-a, a potent stimulator of IL-8 production that is induced
during infection of infant rabbits with V. parahaemolyticus
(Ritchie et al., 2012). TNF-a-stimulated HEK293 cells cocul-
tured with either the vscN1 vopZ0 or the vscN1 vscN2 mutants
produced significantly more IL-8 than cells cocultured with the
vscN1 strain that translocates VopZ (Figure 2A). Furthermore,
reintroduction of WT vopZ into the vscN1 vopZ0 mutant
reduced IL-8 levels, both in the absence and presence of
TNF-a, confirming that disruption of vopZ accounts for the
phenotype of the vopZ0 mutant. VopZ also blocked IL-8 upre-
gulation in HeLa cells in response to IL-1b (Figure 2B),
suggesting that VopZ acts upon a shared component of the
IL-1b and TNF-a response pathways, rather than a receptor-
specific element. Finally, VopZ aa 38–62, which were important
for punctae formation, also appeared to be important for
inhibition of IL-8 production. Cells infected with vscN1
vopZD38–62 and vscN1 vopZ0 secreted indistinguishable
amounts of IL-8, in response to both TNF-a and IL-1b (Figures
2A and 2B). Notably, the vopZD38–62 mutation did not impair
VopZ translocation (Figure S2C), nor did it affect adhesion of
V. parahaemolyticus to host cells (data not shown), suggesting
that aa 38–62 contribute directly to the protein’s effect on the
host cell signaling pathways involved in IL-8 production.
VopZ Inhibits NF-kB Activation
Induction of IL-8 production in response to TNF-a, IL-1b, and/
or bacterial infection is largely dependent on NF-kB and
MAPK pathway activation (Hoffmann et al., 2002). To begin
to define how VopZ inhibits IL-8 production, we tested
whether VopZ altered TNF-a-induced translocation of the
p65 (RelA) subunit of NF-kB into the nucleus, which is neces-
sary for canonical NF-kB pathway target gene induction. HeLa
cells were infected with V. parahaemolyticus for 1 hr (which is
sufficient for T3SS2 effector translocation) and then stimulated
with TNF-a. Subsequent analysis of p65 subcellular locali-
zation, using confocal immunofluorescence microscopy,
revealed that nuclear p65 was far less evident in cells infected
with vscN1 V. parahaemolyticus (20% of cells) than in unin-
fected cells (78% of cells; Figure 2Ca versus Figure S4). In
comparison to vscN1-infected cells, nuclear p65 was twice
as prevalent in vscN1 vscN2, vscN1 vopZ0, and vscN1
vopZD38–63-infected cells (53%, 44%, and 40%, respectively,
of cells; Figure 2C). There is no statistically significant differ-
ence between p65 translocation by cells infected with the
three strains of V. parahaemolyticus that lack intact vopZ or
vscN2; however, infection by all three mutants appears to
have a residual effect on p65 translocation (relative to unin-
fected cells; p < 0.05), suggesting that V. parahaemolyticus
also has T3SS1- and T3SS2-independent means of modu-
lating this process. The phenotype of the vopZ0 mutant could
be complemented by plasmid-expressed VopZ (Figure 2Ce;
22.6% nuclear p65). Transfected VopZ similarly inhibited p65
nuclear translocation in HeLa cells. Thirty minutes followingCTNF-a treatment, only 19% of VopZ-transfected cells con-
tained nuclear p65, versus 78% of untransfected cells (Fig-
ure S4). By contrast, transfected VopZD38–62 had minimal
effect on p65 translocation (Figure S4). These analyses sug-
gest that VopZ inhibits IL-8 production, at least in part, by
preventing p65 nuclear translocation.
A variety of additional experiments confirmed that VopZ in-
hibited NF-kB activation. To confirm that VopZ blocks NF-kB
target gene upregulation, we used HEK293 cells containing a
stably integrated GFP reporter of NF-kB pathway activity
(Gewurz et al., 2011). TNF-a stimulation similarly upregulated
GFP expression in uninfected cells and in cells infected with
the vscN1 vscN2, vscN1 vopZ0, or vscN1 vopZD38–62 strains
for 90 min prior to TNF-a treatment. In contrast, cells infected
with the vscN1 strain exhibited significantly lower NF-kB
GFP reporter intensity in response to TNF-a treatment (Fig-
ures 3A and 3B). VopZ also modulated NF-kB reporter acti-
vation in response to V. parahaemolyticus in the absence
of TNF-a stimulation (Figure 3C), as seen above for IL-8
production.
To further characterize the mechanism of VopZ function, we
studied its effect on turnover of IkBa, an inhibitory factor that
retains p65 NF-kB complexes in the cytosol (Hayden andGhosh,
2012). Canonical NF-kBpathways trigger activation of the kinase
IKK-b, which phosphorylates IkBa and triggers its proteasomal
degradation (Hayden and Ghosh, 2012). In HEK293 cells
infected with V. parahaemolyticus and subsequently treated
with TNF-a, the presence of VopZ (but not VopZD38–62) pre-
vented IkBa degradation that was otherwise apparent within
15 min of TNF-a treatment (Figures 3D and 3E). Collectively,
these results indicate that VopZ blocks canonical NF-kB activa-
tion at or above the level of IkBa degradation and that this effect
requires VopZ residues 38–62.
V. parahaemolyticus Infection Does Not Inhibit
Noncanonical NF-kB Pathway Activation
Signaling via the noncanonical NF-kB pathway triggers activa-
tion of the IKK-a kinase, which phosphorylates p100, the
precursor of the p52 NF-kB transcription factor. This phos-
phorylation triggers p100 cleavage into the active p52 form,
followed by nuclear translocation of p52 homodimers and
p52/RelB heterodimers (Sun, 2011). We tested whether VopZ
can block noncanonical NF-kB activation using HEK293 cells
that inducibly express the Epstein-Barr virus Latent Membrane
Protein 1 (LMP1), a potent activator of this pathway (Luftig
et al., 2004). In contrast to its inhibitory effects on the canon-
ical pathway, V. parahaemolyticus infection did not block
generation of p52 in response to LMP1 expression (Figure 3F).
These data suggest that VopZ’s target is a component of the
canonical, but not the noncanonical, pathway for NF-kB
activation.
VopZ Inhibits MAPK Pathway Activation
Many of the stimuli that lead to NF-kB activation (e.g., cytokines
and various ligands for Toll-like receptors) concurrently activate
both canonical NF-kB and pathways regulated by the MAPKs
JNK and p38. Therefore, we explored whether VopZ also impairs
activation of these MAPKs, which could indicate that it targets aell Reports 3, 1690–1702, May 30, 2013 ª2013 The Authors 1693
Figure 2. VopZ Inhibits Release of IL-8 and Nuclear Translocation of p65
(A) IL-8 release by HEK293 cells was monitored following infection with the indicated strains of V. parahaemolyticus using cells either treated (gray bars) or not
treated (white bars) with TNF-a.
(B) IL-8 release by HeLa cells was monitored following infection with the indicated strains of V. parahaemolyticus using cells either treated (gray bars) or not
treated (white bars) with IL-1b.
(C) p65was visualized using immunofluorescencemicroscopy in HeLa cells that were infected (1 hr) with the indicated strains of V. parahaemolyticus, then treated
with TNF-a (20 ng/ml). Nuclei were visualized with DAPI (blue), and p65 was detected with p65 antisera (red). White arrows indicate cells with cytoplasmic p65;
yellow arrows mark cells with nuclear p65. Mean values (n = 3) and SD are shown.
For (A) and (B), IL-8 levels in supernatants were measured via ELISA; mean values (n = 2) and SD are shown. The asterisk (*) indicates statistical difference
(p < 0.05) when compared to vscN1-infected cells without TNF treatment; the double asterisks (**) indicate statistical difference (p < 0.05) when compared to
vscN1-infected cells with TNF-a or IL-1b treatment. See also Figure S4.
1694 Cell Reports 3, 1690–1702, May 30, 2013 ª2013 The Authors
Figure 3. VopZ Inhibits Canonical NF-kB
Pathway Activation
(A and B) HEK293 NF-kB GFP reporter cells were
infected for 90 min and then stimulated by TNF-a
(1 ng/ml) for 6 hr. GFPmean fluorescence intensity
(M.F.I.) (A) and representative FACS overlay plots
(B) are shown.
(C) HEK293 NF-kB GFP reporter cells were
infected for 90 min, and NF-kB activity was
analyzed 15 hr later.
(D and E) VopZ inhibits IkBa turnover. HEK293
cells were infected with V. parahaemolyticus
strains for 90 min, then stimulated by TNF-a
(1 ng/ml) for the indicated times. Tubulin (D) and
p65 (E) are loading controls.
(F) HEK293 cells were infected with the indicated
strains for 90 min and then noncanonical NF-kB
signaling was stimulated by LMP1 expression for
12 hr. Noncanonical NF-kB pathway activation
induces cleavage of p100 into p52.
For (A) and (C), duplicate samples from three
independent experiments were used to obtain
M.F.I. and SD data. Student’s two-tailed paired
t test p values are denoted. All samples bracketed
were found to differ significantly from the vscN1
control strain. Western blots representative of
three independent experiments are shown (D–F).factor common to these pathways. JNK and p38 kinase activa-
tion loop phosphorylation was used as a readout of their activa-
tion state. We observed, using HEK293 cells infected with
V. parahaemolyticus and subsequently stimulated with TNF-a,
that JNK and p38 phosphorylation (but not protein abundance)
was markedly lower following infection with the vscN1 or
vscN1 vopZ0 pVopZ strains than with the vscN1 vscN2, vscN1
vopZ0, or vscN1 vopZD38–62 strains (Figures 4A and 4B).
Furthermore, infection with V. parahaemolyticus strains that
lack VopZ triggered MAPK phosphorylation even prior to
TNF-a stimulation, which was also blocked by VopZ. These
results suggest that VopZ antagonizes multiple MAPK pathways
and that as for NF-kB, this inhibitory effect is dependent upon
VopZ aa 38–62.
VopZ Prevents TAK1 Activation
The cellular pathways leading to canonical NF-kB activation and
MAPK induction in response to several ligands, including IL-1b
and TNF-a, converge at TAK1 (Sakurai, 2012; Hayden andCell Reports 3, 1690–170Ghosh, 2011), which is not a component
of the noncanonical NF-kB activation
pathway (Figure 5A). Thus, altered activa-
tion of TAK1 could account for all the
effects of VopZ that we have observed.
In support of this hypothesis, we ob-
served that the presence of VopZ
prevented accumulation of TAK1 phos-
phorylated on Thr184 in HEK293 cells
infected with V. parahaemolyticus, both
in response to the bacteria alone (Fig-
ure 5B, time = 0 min) and in response tobacterial infection followed by TNF-a treatment (Figure 5B,
time = 15min). Such activation loop phosphorylation is important
for the induction of TAK1 activity (Kishimoto et al., 2000). Further-
more, full-length VopZ prevented the autophosphorylation of
TAK1 that occurs upon its overexpression in transfected
HEK293 cells, as well as subsequent activation of its down-
stream target p38 (Figure 5C). In contrast, VopZ had no effect
upon phosphorylation/autoactivation of transfected MKK6 or
on MKK6-mediated phosphorylation of p38 (Figure 5D). Finally,
infection with the vscN1 mutant, but not the vscN1 vopZ0 strain,
impaired the kinase activity of transfected TAK1. Following
90 min of coculture with V. parahaemolyticus, FLAG-tagged
TAK1 was immune purified from transfected HEK293 cells and
tested in an in vitro kinase assay with recombinant kinase-defi-
cient MKK6 (MKK6K82A) (Paquette et al., 2012). TAK1 purified
from cells infected with the vscN1 vopZ0 strain was significantly
more active than that purified from cells cocultured with the
vscN1 mutant, even though there were very similar amounts of
TAK1 in the assays (Figure 5E). Collectively, these data strongly2, May 30, 2013 ª2013 The Authors 1695
Figure 4. VopZ Inhibits MAPK Pathway Activation
(A and B) Activation of p38 and JNK was assessed using antibodies to total
and phosphorylated forms of proteins. HEK293 cells were infected with
V. parahaemolyticus strains for 90 min and then stimulated by TNF-a (1 ng/ml).
Western blots representative of three independent experiments are shown.suggest that VopZ inhibits activation of MAPK and the canonical
NF-kB pathway via limiting accumulation of activated TAK1
(Figure 5A).
VopZ Contributes to V. parahaemolyticus Intestinal
Colonization and Disease in Infant Rabbits
We used the infant rabbit model of V. parahaemolyticus infec-
tion to explore whether this pathogen requires VopZ to colonize
the small intestine and/or cause disease. Strikingly, truncation
of VopZ (i.e., vopZ0) reduced intestinal colonization, diarrhea/
fluid accumulation, and intestinal pathology to nearly the
same extent as did inactivation of the entire T3SS2 (via deletion
of vscN2) (Figure 6), even though our vitro analyses suggest that
T3SS2 is fully functional in a vopZ0 background. The effect of
vopZ truncation on colonization and fluid accumulation was
eliminated when the mutant strain contained a plasmid encod-
ing WT VopZ, thereby confirming that the vopZ0 mutation
accounts for the mutant’s phenotypes (Figures 6A and 6B).
These data indicate that VopZ, unlike all T3SS2 effectors
described to date, is critical for V. parahaemolyticus coloniza-
tion and disease.
Interestingly, in contrast to all assays described above, the
effects in infant rabbits of the vopZ0 and vopZD38–62 mutations
were not equal. The absence of VopZ aa 38–62, unlike
VopZ truncation, did not interfere with the capacity of
V. parahaemolyticus to colonize the infant rabbit intestinal tract1696 Cell Reports 3, 1690–1702, May 30, 2013 ª2013 The Authors(Figure 6A). Thus, VopZ’s contribution to intestinal colonization
does not appear to be dependent on modulation of TAK1
activation, suggesting that VopZ must have an additional, and
genetically separable, function. Notably, deletion of VopZ aa
38–62 also did not influence infiltration of heterophils into intes-
tinal tissue (Figure S5A), and the presence of WT VopZ versus
VopZD38–62 did not affect the abundance of transcripts for
IL-8, TNF-a, and IL-1b in intestinal tissue (data not shown).
However, it should be noted that in vivo, these markers of
inflammation can be induced by numerous stimuli and path-
ways and are not expected to be fully dependent upon epithelial
cell TAK1.
Furthermore, although this internal vopZ deletion did not
reduce the bacterial load or appear to influence several markers
of inflammation in the rabbit intestine, this mutation nonetheless
had a dramatic effect upon critical signs of disease. The
vopZD38–62 mutation eliminated gross manifestations of infec-
tion, including diarrhea and fluid accumulation, in infected
rabbits (Figure 6B). As seen in vitro, the absence of VopZ aa
38–62 was also associated with an increase in the frequency of
nuclear p65, consistent with the role of these aa in blocking
TAK1 activation (Figure 7A). Additionally, the vopZD38–62 muta-
tion markedly reduced the epithelial disruption typically
observed with V. parahaemolyticus infection (Figure 7B). The
presence of WT VopZ, rather than VopZD38–62, was associated
with increased epithelial cell sloughing (Figure 6C) and disruption
of filamentous actin at the villus surface (Figure S5B), alterations
likely to reflect a loss of epithelial barrier function. These obser-
vations are consistent with previous analyses that have reported
disruption of the murine intestinal epithelium and loss of barrier
function in response to TAK1 deficiency (Kajino-Sakamoto
et al., 2008, 2010). Coupled with our in vitro data, our in vivo
results suggest that VopZ-dependent inhibition of TAK1 activa-
tion is critical to the development of V. parahaemolyticus-linked
intestinal pathology.
DISCUSSION
Previous studies using animal models of V. parahaemolyticus
pathogenicity have revealed that T3SS2 is critical for this path-
ogen to colonize the intestine and to cause disease (Park et al.,
2004; Hiyoshi et al., 2010; Pin˜eyro et al., 2010; Ritchie et al.,
2012). Here, we found that VopA, VopT, and VopL—the three
T3SS2-secreted effectors known when this work was initi-
ated—are not required by V. parahaemolyticus to colonize the
infant rabbit intestine or induce disease. Additionally, we
identified T3SS2-secreted proteins, two of which (VPA1343
and VPA1350) are likely to be components of the secretion/
translocation apparatus. The third protein, VopZ (VPA1336),
is an uncharacterized T3SS2-encoded/-secreted polypep-
tide with no recognizable functional domains. We discovered
that VopZ, unlike VopA, VopT, and VopL, is an essential viru-
lence factor. Furthermore, VopZ appears to play distinct, genet-
ically separable roles in enabling V. parahaemolyticus to
colonize the intestine and to cause diarrhea. Truncation of
VopZ prevented V. parahaemolyticus colonization as well as
all signs of disease; however, deletion of VopZ aa 38–62 abro-
gated V. parahaemolyticus-induced diarrhea/intestinal fluid
Figure 5. VopZ Inhibits TAK1 Activation
(A) Schematic of signaling pathways leading to
activation of MAPKs and canonical and nonca-
nonical NF-kB, and possible site of VopZ action.
CM, cell membrane; NM, nuclear membrane.
(B) HEK293 cells were infected with
V. parahaemolyticus strains for 90 min and then
stimulated by TNF-a (1 ng/ml). Activation of TAK1
was assessed using antibodies to total and T184/
T187-phosphorylated TAK1.
(C and D) TAK1, but not MKK6, autophosphor-
ylation and activity are inhibited by VopZ. FLAG-
TAK1 or MKK6 was transiently expressed in
HEK293 cells, which were then infected for 90 min
with the indicated strains. Activation of TAK1,
MKK6, and P38 was assessed using antibodies to
total and phosphorylated forms of proteins.
(E) WT or K63W (kinase-deficient) TAK1 was
immunopurified from transfected HEK293 cells
that had been infected with the indicated strains
for 90 min prior to harvest. TAK1 activity was
monitored using a cold kinase assay, followed by
detection of phosphorylated substrate (recombi-
nant kinase-deficient MKK6-K82A) via immuno-
blotting. Phospho-and total TAK1 levels were also
monitored by immunoblot. Western blots repre-
sentative of three independent experiments are
shown.accumulation and most histopathologic signs of disease but did
not impair V. parahaemolyticus’ capacity to colonize the small
intestine, indicating that regions outside of VopZ aa 38–62
mediate VopZ’s role in colonization. The correlation between
VopZ aa 38–62 dependent inhibition of TAK1 in vitro, aa
38–62 dependent diarrhea and other intestinal pathology in vivo,
and the previously described consequences of intestinal TAK1
deficiency strongly suggests that inhibition of TAK1 activation
by VopZ is a critical facet of V. parahaemolyticus pathogenicity.
VopZ differs from the vast majority of T3SS-secreted effectors
in that it is essential for the virulence of the organism that pro-
duces it. Intestinal colonization by V. parahaemolyticus lacking
VopZ is reduced by several orders of magnitude relative to the
WT strain, and infected animals do not display overt signs of
infection, such as diarrhea or intestinal fluid accumulation. InCell Reports 3, 1690–170contrast, deletions of individual T3SS
effectors in other organisms, like our
deletions of the previously described
T3SS2 effectors VopA, VopT, and VopL,
frequently have a relatively subtle effect
on pathogenesis (Gala´n, 2009; Dean,
2011). One of the few effectors known to
be required for virulence is the EHEC pro-
tein Tir, which enables formation of the
hallmark tight association between the
bacteria and the host tissue. However,
our in vitro analyses (data not shown) sug-
gest that mutations in vopZ, unlike those
in tir (DeVinney et al., 1999), do not impair
adherence of bacteria to eukaryotic cells.
Future analyses will aim to identify theprecise regions of VopZ, as well as the mechanisms, that enable
VopZ to contribute to intestinal colonization.
TAK1, whose activation we found was effectively blocked by
VopZ (Figure 5), has previously been shown to have a profound
effect on maintenance of intestinal integrity. The absence of
TAK1 in the intestinal epithelium results in a plethora of pheno-
types, including inflammation, apoptosis of crypt cells, distorted
epithelial structure, mislocalization of tight junction proteins, and
reduced transepithelial resistance (Kajino-Sakamoto et al.,
2008). TAK1-deficient intestinal epithelium also contains in-
creased levels of reactive oxygen species and is hypersensitive
to oxidative stress (Kajino-Sakamoto et al., 2010). Thus, even
though TAK1 activation has consequences associated with
inflammation (e.g., NF-kB and MAPK signaling) in an in vitro
system, in the more complex milieu of an intact organism,2, May 30, 2013 ª2013 The Authors 1697
Figure 6. VopZ Makes Distinct and
Genetically Separable Contributions to
V. parahaemolyticusColonization and Path-
ogenesis within the Infant Rabbit Small
Intestine
Bacterial colonization (cfu/g) in intestinal tissue (A)
and intestinal fluid accumulation ratios (B) for
infant rabbits infected with the indicated strains of
V. parahaemolyticus at38 hr postinfection. Lines
in (A) show geometric means. Means and SEM,
based on at least nine rabbits, are shown in (B).
Data for the vscN1 and vscN2 strains were previ-
ously published (Ritchie et al., 2012). Tissue
sloughing (C) in tissue from distal intestines of
infected infant rabbits was scored as described
(Ritchie et al., 2012); median values are indicated.
Statistical significance was assessed with one-
way ANOVA and Bonferroni’s posttests: *p < 0.05,
**p < 0.01, ***p < 0.001, or as indicated on the
graphs.TAK1 deficiency is also associated with inflammation. Similarly,
conditional ablation of IKK-g, a scaffold necessary for canonical
NF-kB activation, produced enterocyte damage, which then
allows bacterial translocation and dramatic Toll-like receptor-
dependent inflammation in vivo (Nenci et al., 2007). Thus,
whereas in vitro analyses using a homogeneous cell popula-
tion are extremely valuable for precise dissection of signal
transduction pathways and their regulatory processes, they
often fail to fully represent the complex phenotypes that can
ensue from the interplay of multiple cell types and flora within
the intact intestine. It is likely that the differences we have
observed between the role of VopZ in vitro and in vivo (e.g.,
VopZ’s lack of an effect in vivo on total cytokine levels) are anal-
ogous to those seen in analyses of TAK1 in vitro and in vivo, in
that they are a consequence of the greater complexity of the
in vivo system.
In contrast to the engineered mice, where TAK1 is uniformly
deficient in the intestinal epithelium, mice infected with
V. parahaemolyticus likely have suppressed TAK1 activity only
in a subset of cells. During infection, V. parahaemolyticus gener-
ally forms discrete clusters rather than being distributed across
the epithelial surface (Ritchie et al., 2012), and VopZ and other
T3SS2 effectors are thus unlikely to be transmitted to the entire
intestinal epithelium. Consequently, VopZ’s effects on TAK1
signaling are probably best measured at the level of single cells,
such as the changes we observed in p65 nuclear translocation or
in the actin cytoskeleton, rather than tissue wide, such as
changes in gene expression or in the level of secreted factors.
Still, there are noteworthy similarities between the reduced
epithelial integrity observed in response to TAK1 deficiency
and infection with VopZ-secreting V. parahaemolyticus. Further-1698 Cell Reports 3, 1690–1702, May 30, 2013 ª2013 The Authorsmore, local disruptions in tissue integrity
(e.g., in response to translocated VopZ)
can have a profound effect upon its
barrier function, for example by allowing
bacterial translocation that can subse-
quently provoke a vigorous immune
response and/or serve as a trigger formore comprehensive disruption (Baldwin, 2012). Such local
disruptions are thought to underlie the role in virulence of YopJ
(discussed below), a T3SS effector in Yersinia with somewhat
analogous effects on signaling to those of VopZ. Our analyses
of VopZ’s significance in vitro and in vivo suggest that focal inhi-
bition of TAK1 activity in the intestinal epithelium has a marked
effect upon the integrity of this tissue and plays a critical role in
the virulence of V. parahaemolyticus.
Numerous factors and pathways are known to lead to TAK1
activation, including TNF-a and other cytokines, LPS, DNA
damage, osmotic shock, and hypoxia (Dai et al., 2012). It has
also been proposed that different processes govern basal versus
stimulus-dependent TAK1 activation, mediated by the TAK1-
associated proteins TAB1 and TAB2/TAB3, respectively (Omori
et al., 2012). The fact that VopZ inhibits TAK1’s activation via a
variety of agents and activating processes (e.g., IL-1b, TNF-a,
and microbe-dependent activation) whose pathways converge
at the level of TAK1 activation, suggests that it likely acts either
on TAK1 itself or on a factor that is routinely associated with it,
such as TAB1. Our finding that VopZ inhibits TAK1 activation
following transfection and overexpression—a process that is
thought to be mediated by enhanced TAK1 oligomerization
and to be independent of upstream stimuli—also supports that
idea that VopZ acts at the level of the TAK1 protein complex,
rather than in upstream activation pathways. VopZ might inter-
fere with induction of the TAK1 conformational shift that is
thought to enable activating autophosphorylation, either via
interacting with a TAB protein or with TAK1 itself. Alternatively,
VopZ might increase the activity of a TAK1-associated phos-
phatase, such as the type 2A protein phosphatase PP6 (Kajino
et al., 2006), or possess phosphatase activity itself, although
Figure 7. Production of VopZD38–62 In Vivo
Is Associated with Increased Nuclear p65
and Reduced Disruption of the Intestinal
Epithelium
(A) Immunofluorescence microscopy was used
to detect p65 (red) in frozen sections of distal
small intestines from rabbits infected with
V. parahaemolyticus for 28 hr. Nuclei were stained
with DAPI (blue). Arrows indicate nuclear p65.
(B) Tissue from the distal small intestines of
rabbits infected with the indicated strains of
V. parahaemolyticus for 38 hr was stained with
H&E. Arrows indicate bacterial microcolonies.no conserved enzymatic domains were detected. The TAK1-
inhibitory activity of VopZ was correlated with punctate localiza-
tion of VopZ; however, it is currently unclear whether VopZ’s
localization directly contributes to its activity.
Although VopZ is not homologous to known T3SS effectors,
other effectors are known to interfere with TAK1 activity. The
best characterized of these is the Yersinia protein YopJ, an ace-
tyltransferase. YopJ acetylates the activation loop of TAK1,
which inhibits TAK1 phosphorylation/activation, and thereby
prevents activation of downstream pathways (Meinzer et al.,
2012; Paquette et al., 2012). YopJ, like VopZ, contributes to
disruption of the intestinal epithelium and its barrier function
during infection (Meinzer et al., 2012). However, it should be
noted that YopJ has multiple additional substrates, including
MKK6, p38, JNK, and IKKb (Mittal et al., 2006; Mukherjee
et al., 2006); consequently, the pathways modulated by YopJ
and VopZ may not entirely coincide. The EPEC/EHEC protein
NleE also reduces TAK1 activation by methylating TAB2 and
TAB3 (Zhang et al., 2012), but roles for this effector during infec-
tion have yet to be described. Additional effectors, such as
VopA, AvrA, OspF, SpvC, and HopAI1, have been found to
target factors downstream of TAK1, such as MAPKKs and
MAPKs, suggesting that disruption of the pathways controlled
by TAK1 is beneficial for a variety of pathogens (Gala´n, 2009;
Dean, 2011). In our experiments, it is somewhat surpris-
ing that we do not observe more inhibition of the MAPKCell Reports 3, 1690–170pathways by the vopZ mutants versus
the vscN2 mutant because the former
strains still produce VopA; this result
suggests that VopZ may be the domi-
nant inhibitor of MAPKs generated by
V. parahaemolyticus.
Finally, our findings may have potential
clinical applications. First, because the
V. parahaemolyticus vopZD38–62mutant
robustly colonizes the intestine yet
does not cause diarrhea, it may be
possible to create a live attenuated
V. parahaemolyticus vaccine based on
this strain. Optimization of vopZD38–62-
based vaccine may require inclusion of
additional attenuating mutations. Such a
vaccine could also potentially deliverheterologous substrates to the intestinal mucosa, as proposed
previously for Salmonella-based vaccines (Ru¨ssmann et al.,
1998). Finally, immunomodulatory fragments of VopZ coupled
to cell-permeable peptides could have therapeutic utility for
patients with inflammatory conditions.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions
All strains are derived from RIMD2210633 (Makino et al., 2003). vscN1, vscN2,
and vscN1/vscN2 strains have been previously described by Hiyoshi et al.
(2010). Additional mutants, including vpa1343, vpa1350, vscN1 vopZ0, and
vscN1 vopZD38–62 strains, were created by allele exchange using suicide
vector pDM4 as previously described (Zhou et al., 2008). Plasmids pVopZ-
His (for vopZ complementation), pVopZ-CyaA, pVopZD38–62-CyaA, pVopV-
CyaA, and pVtrB were constructed using the vector pMMB207 (Morales
et al., 1991) and introduced into V. parahaemolyticus strains via conjugation.
HA-fusion constructs for full-length and truncated vopZ were constructed in
pCMVHA (Clontech). Strains were cultured in LB medium at 37C and supple-
mented with appropriate antibiotics. Expression vectors for FLAG-tagged
human TAK1 and MKK6 have previously been described by Paquette et al.
(2012). Recombinant MKK6K82A was purified as previously described by
Paquette et al. (2012).
Eukaryotic Cell Lines and Culture Conditions
HeLa, Caco-2, and HEK293 cells were routinely maintained in DMEM (GIBCO)
supplemented with 10% FBS (Clontech) at 37C with 5% CO2. For in vitro
infection assays, bacterial cells were grown in LB supplemented with 0.04%
sodium cholate for 2 hr to induce the expression of T3SS2.2, May 30, 2013 ª2013 The Authors 1699
2D Gel Analysis and Western Blot Analysis of Bacterial Proteins
To obtain proteins for 2D PAGE analysis, RIMD2210633 vscN1 pVtrB and
RIMD2210633 vscN1 vscN2 pVtrB were cultured in DMEM containing 1 mM
IPTG to induce expression of the T3SS2 activator, VtrB. After 3 hr of growth,
cells were removed by centrifugation and filtration, and DIGE analysis was
performed on the culture supernatant by Applied Biomics (Hayward, CA,
USA). Western blot analysis was performed on cell pellets and supernatants
from bacteria cultured in LB supplemented with 1 mM IPTG.
Effector-CyaA Fusion Protein-Based Analysis of Effector
Translocation
Caco-2 cells were cultured for 10 days to achieve differentiation. Differentiated
Caco-2 cells were infected with RIMD2210633 vscN1 and RIMD2210633
vscN1 vscN2 containing pCyaA, pVopZ-CyaA, pVopZD38–62-CyaA, or
pVopV-CyaA for 1 hr in the presence of 0.04% sodium cholate and then
cAMP levels were determined by ELISA as described previously (Zhou et al.,
2012b).
Immunofluorescence Detection of VopV Translocation
HeLa cells grown overnight on glass coverslips were infected with
V. parahaemolyticus overexpressing vtrB for 1 hr before being fixed with 4%
formalin. Fixed cells were blocked with PBS containing 3% BSA for 1 hr,
then VopV was detected with rabbit anti-VopV antisera (generously provided
by Dr. Toshio Kodama) and FITC-goat anti-rabbit IgG (Sigma-Aldrich). Actin
was stained with rhodamine phalloidin, and DNA was stained with DAPI.
Transfection and Visualization of VopZ within HeLa Cells
HeLa cells grown overnight on coverslips were transfected with HA-VopZ
expression constructs using Lipofectamine 2000 (Life Technologies).
Twenty-four hours after transfection, cells were fixed with 4% formalin, and
full-length and truncated VopZs were detected by immunofluorescence using
anti-HA (Sigma-Aldrich) and FITC-conjugated anti-mouse IgG (Sigma-
Aldrich).
p65 Translocation Assays
HeLa cells grown overnight on coverslips were transfected with HA-VopZ
expression constructs for 24 hr or infected with V. parahaemolyticus strains
for 1 hr in the presence of 0.04% sodium cholate. After treatment with
TNF-a (R&D Systems; 20 ng/ml) for 1 hr, cells were fixed, and p65 localization
was detected using anti-p65 (Cell Signaling). For each of three transfection
experiments, p65 localization was assessed in 30 cells with detectable
VopZ. For each of three infection experiments, p65 localization was deter-
mined in 30 randomly selected cells. For in vivo assays of p65 translocation,
frozen sections of distal small intestines from the rabbits infected with
V. parahaemolyticus for 28 hr were stained with anti-p65 primary antibody
(Cell Signaling) and Alexa Fluor 568 goat anti-mouse IgG secondary antibody.
Nuclei were stained with DAPI. Localization of p65 was determined in three
fields with 30 cells/field.
NF-kB Activity and IL-8 Production in HEK293 and HeLa Cells
HEK293 cells in which GFP reporter expression is controlled by four tandem
NF-kB sites (Gewurz et al., 2012) were infected with V. parahaemolyticus for
90 min in the presence of 0.04% sodium cholate and then infection was
terminated by addition of gentamicin (200 ng/ml). Cells were then cultured
an additional 4–5 hr, either in the presence or absence of TNF-a (1 ng/ml).
GFP expression was detected via FACS Calibur (BD; Gewurz et al., 2012).
For assays of IL-8 production, HEK293 cells or HeLa cells were infected with
V. parahaemolyticus for 90 min, then treated with TNF-a (2 ng/ml; HEK293)
or IL-1b (R&D Systems, 25 ng/ml; HeLa) or left untreated for 90 min. IL-8 in
culture supernatant was then measured via ELISA (BD).
Western Blot Analyses of Host Proteins
HEK293 cells were infected with V. parahaemolyticus at an approximate moi of
5:1 for 90 min in the presence of 0.04% sodium cholate, and infection was
terminated by addition of gentamicin (200 ng/ml). Infected cells were stimu-
lated with TNF-a (1 ng/ml), then lysed as described (Gewurz et al., 2011) at
the indicated time points poststimulation. Protein samples were electrophor-1700 Cell Reports 3, 1690–1702, May 30, 2013 ª2013 The Authorsesed on SDS-PAGE 10% gels, transferred to nitrocellulose membranes, and
probed with Cell Signaling antibodies against IkBa (#9242), phospho-JNK
(#9251), phospho-p38 (#9211), total JNK(#9252), and total p38(#9212). For
detection of endogenous (but not transfected) phospho-TAK1, cells were
stimulated with TNF-a in the presence of 50 nM Calyculin A, and pTAK1 was
detected with #4536. Also used were anti-Tubulin (Sigma-Aldrich; T5168)
and anti-LMP1 monoclonal S12.
Epistasis Experiments
HEK293 cells (4 3 105) were reverse transfected in 6-well plates with FLAG-
TAK1 orMKK6 using Effectene (QIAGEN), as indicated. Forty-eight hours later,
cells were split 1:2 into 12-well plates and then infected 24 hr later with the
indicated bacterial strains for 90 min. Whole-cell lysates were subjected to
SDS-PAGE and western blot as described above. Of note, cells were not
treated with Calyculin A for pTAK1 detection.
Kinase Assay
HEK293 cells (33 106) were Effectene reverse transfected with FLAG-TAK1 or
FLAG-TAK1-K63W (a kinase-dead mutant). Forty-eight hours later, cells were
split 1:2 and then 24 hr thereafter, infected for 90 min with the indicated
bacterial strain. FLAG-TAK1 was then immunoprecipitated and used in
cold in vitro kinase reactions with recombinant HIS-tagged MKK6-K82A, as
previously described by Paquette et al. (2012). Kinase assays were subject
to SDS-PAGE, and western blots were probed for pTAK1 and pMKK6, and
reprobed with anti-FLAG (Sigma-Aldrich M2 antibody) for total TAK1.
Detection of Noncanonical NF-kB Activation
HEK293 cells were infected with V. parahaemolyticus for 90 min, and infection
was terminated by gentamicin addition (200 ng/ml). Infected cells were sub-
sequently stimulated with LMP1 residue 1–231 expression for approximately
8 hr, lysed with 1% NP40 lysis buffer, and electrophoresed as described
above. Membranes were probed with anti-p100/p52 (Millipore; #05-361).
Infection of Infant Rabbits
Infant rabbits were infected as described previously (Ritchie et al., 2012).
Briefly, cimetidine-treated rabbits were orogastrically inoculated with 109 cfu
of V. parahaemolyticus, and bacterial colonization (cfu/g intestinal tissue)
and fluid accumulation were measured 38 hr postinfection. Translocation of
p65 and actin localization were determined 28 hr postinfection in order to
assess less-disrupted tissues. Fluid accumulation ratios for the distal small
intestine were determined by isolating an approximately 5 cm length of tissue
using silk ligatures. The intestinal section was weighed and then cut every
0.5 cm to release any luminal fluid, and the tissue pieces were reweighed.
The fluid accumulation ratio was calculated as the weight of fluid divided
by the weight of the drained tissue. Histological scores were graded by a
pathologist.
All animal experiments were performed in accordance with a protocol
approved by the Harvard IACUC.
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